Viewing Study NCT07249905

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:21 AM
Ignite Modification Date: 2026-04-14 @ 4:36 PM
Study NCT ID: NCT07249905
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-11-25
First Post: 2025-11-18
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: This Study is Designed to Characterize the Safety, Tolerability, and Anti-tumor Activity of MDX2003 in Patients With Different Types of Lymphoma
Sponsor: ModeX Therapeutics, An OPKO Health Company
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
None Waldenström Macroglobulinemia (WM) View
None DLBCL - Diffuse Large B Cell Lymphoma View
None PMBCL View
None HGBCL View
None FL Lymphoma View
None Lymphoplasmacytic Lymphoma View
None Follicular Lymphoma (FL) View
Keywords: